Clinical Trials Browser

Phase 3 × Carcinoma, Hepatocellular × brivanib × Clear all

NCT00908752 2019-12-02

BRISK TA

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT01108705 2015-10-12

BRISK-APS

Phase 3 Terminated

Gastrointestinal

Carcinoma, Hepatocellular